Verwandte Artikel zu Small Cell Lung Cancer: DE
Inhaltsangabe
Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy that is highly metastatic and typically diagnosed at advanced stages, resulting in poor prognosis. It accounts for 13-15% of all lung cancers and is strongly associated with smoking. The disease's rapid progression, tendency to develop resistance to chemotherapy, and frequent metastasis to the brain, liver, and bones present significant challenges for treatment. Initial therapy with chemotherapy, primarily platinum-based regimens, often yields good responses in limited-stage disease, but relapse occurs rapidly in most patients, with extensive-stage disease showing minimal long-term survival benefits. Recent advances in immunotherapy, particularly immune checkpoint inhibitors, have shown promise in improving outcomes, especially when combined with chemotherapy. Additionally, targeted therapies directed at specific molecular alterations such as MYC amplification and BCL2 overexpression are currently under investigation. Liquid biopsy technologies and molecular profiling are revolutionizing early detection and personalized treatment, offering hope for better treatment strategies.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Über die Autorin bzw. den Autor
Dr. Wala BEN KRIDIS est professeur associé à la faculté de médecine de Sfax (Tunisie).Elle est titulaire d'un diplôme de médecine en oncologie (MD).Elle est titulaire d'un doctorat en sciences biologiques.Maîtrise en recherche clinique en sciences médicales.Réviseur pour Lancet Oncology.Rédactrice pour PLOS One.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Suchergebnisse für Small Cell Lung Cancer: DE
Beispielbild für diese ISBN
Small Cell Lung Cancer
Anbieter: PBShop.store US, Wood Dale, IL, USA
Verkäuferbewertung 5 von 5 Sternen
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers L2-9786209440328
Neu kaufen
EUR 48,06
Versand gratis
Versand innerhalb von USA
Versand innerhalb von USA
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Small Cell Lung Cancer
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers L2-9786209440328
Neu kaufen
EUR 47,08
EUR 3,83 Versand
Versand von Vereinigtes Königreich nach USA
Versand von Vereinigtes Königreich nach USA
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Small Cell Lung Cancer
Verlag:
LAP LAMBERT Academic Publishing, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Softcover
Anbieter: California Books, Miami, FL, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers I-9786209440328
Neu kaufen
EUR 52,26
Versand gratis
Versand innerhalb von USA
Versand innerhalb von USA
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Small Cell Lung Cancer
Verlag:
LAP LAMBERT Academic Publishing Jan 2026, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Taschenbuch
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy that is highly metastatic and typically diagnosed at advanced stages, resulting in poor prognosis. It accounts for 13-15% of all lung cancers and is strongly associated with smoking. The disease's rapid progression, tendency to develop resistance to chemotherapy, and frequent metastasis to the brain, liver, and bones present significant challenges for treatment. Initial therapy with chemotherapy, primarily platinum-based regimens, often yields good responses in limited-stage disease, but relapse occurs rapidly in most patients, with extensive-stage disease showing minimal long-term survival benefits. Recent advances in immunotherapy, particularly immune checkpoint inhibitors, have shown promise in improving outcomes, especially when combined with chemotherapy. Additionally, targeted therapies directed at specific molecular alterations such as MYC amplification and BCL2 overexpression are currently under investigation. Liquid biopsy technologies and molecular profiling are revolutionizing early detection and personalized treatment, offering hope for better treatment strategies. 52 pp. Englisch. Bestandsnummer des Verkäufers 9786209440328
Neu kaufen
EUR 43,90
EUR 23,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 2 verfügbar
Foto des Verkäufers
Small Cell Lung Cancer
Verlag:
LAP LAMBERT Academic Publishing, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Taschenbuch
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy that is highly metastatic and typically diagnosed at advanced stages, resulting in poor prognosis. It accounts for 13-15% of all lung cancers and is strongly associated with smoking. The disease's rapid progression, tendency to develop resistance to chemotherapy, and frequent metastasis to the brain, liver, and bones present significant challenges for treatment. Initial therapy with chemotherapy, primarily platinum-based regimens, often yields good responses in limited-stage disease, but relapse occurs rapidly in most patients, with extensive-stage disease showing minimal long-term survival benefits. Recent advances in immunotherapy, particularly immune checkpoint inhibitors, have shown promise in improving outcomes, especially when combined with chemotherapy. Additionally, targeted therapies directed at specific molecular alterations such as MYC amplification and BCL2 overexpression are currently under investigation. Liquid biopsy technologies and molecular profiling are revolutionizing early detection and personalized treatment, offering hope for better treatment strategies. Bestandsnummer des Verkäufers 9786209440328
Neu kaufen
EUR 46,08
EUR 30,50 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Small Cell Lung Cancer
Verlag:
LAP LAMBERT Academic Publishing, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Softcover
Anbieter: Books Puddle, New York, NY, USA
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers 26405700621
Neu kaufen
EUR 86,69
EUR 3,43 Versand
Versand innerhalb von USA
Versand innerhalb von USA
Anzahl: 4 verfügbar
Beispielbild für diese ISBN
Small Cell Lung Cancer
Verlag:
LAP LAMBERT Academic Publishing, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Softcover
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. Print on Demand. Bestandsnummer des Verkäufers 408502226
Neu kaufen
EUR 83,07
EUR 7,56 Versand
Versand von Vereinigtes Königreich nach USA
Versand von Vereinigtes Königreich nach USA
Anzahl: 4 verfügbar
Beispielbild für diese ISBN
Small Cell Lung Cancer (Paperback)
Verlag:
LAP Lambert Academic Publishing, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Paperback
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Paperback. Zustand: new. Paperback. Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy that is highly metastatic and typically diagnosed at advanced stages, resulting in poor prognosis. It accounts for 13-15% of all lung cancers and is strongly associated with smoking. The disease's rapid progression, tendency to develop resistance to chemotherapy, and frequent metastasis to the brain, liver, and bones present significant challenges for treatment. Initial therapy with chemotherapy, primarily platinum-based regimens, often yields good responses in limited-stage disease, but relapse occurs rapidly in most patients, with extensive-stage disease showing minimal long-term survival benefits. Recent advances in immunotherapy, particularly immune checkpoint inhibitors, have shown promise in improving outcomes, especially when combined with chemotherapy. Additionally, targeted therapies directed at specific molecular alterations such as MYC amplification and BCL2 overexpression are currently under investigation. Liquid biopsy technologies and molecular profiling are revolutionizing early detection and personalized treatment, offering hope for better treatment strategies. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Bestandsnummer des Verkäufers 9786209440328
Neu kaufen
EUR 51,52
EUR 43,05 Versand
Versand von Vereinigtes Königreich nach USA
Versand von Vereinigtes Königreich nach USA
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Small Cell Lung Cancer
Verlag:
LAP LAMBERT Academic Publishing, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Softcover
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. PRINT ON DEMAND. Bestandsnummer des Verkäufers 18405700615
Neu kaufen
EUR 86,02
EUR 9,95 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 4 verfügbar
Foto des Verkäufers
Small Cell Lung Cancer
Verlag:
LAP LAMBERT Academic Publishing Jan 2026, 2026
ISBN 10: 6209440320
ISBN 13: 9786209440328
Neu
Taschenbuch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy that is highly metastatic and typically diagnosed at advanced stages, resulting in poor prognosis. It accounts for 13-15% of all lung cancers and is strongly associated with smoking. The disease's rapid progression, tendency to develop resistance to chemotherapy, and frequent metastasis to the brain, liver, and bones present significant challenges for treatment. Initial therapy with chemotherapy, primarily platinum-based regimens, often yields good responses in limited-stage disease, but relapse occurs rapidly in most patients, with extensive-stage disease showing minimal long-term survival benefits. Recent advances in immunotherapy, particularly immune checkpoint inhibitors, have shown promise in improving outcomes, especially when combined with chemotherapy. Additionally, targeted therapies directed at specific molecular alterations such as MYC amplification and BCL2 overexpression are currently under investigation. Liquid biopsy technologies and molecular profiling are revolutionizing early detection and personalized treatment, offering hope for better treatment strategies.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 52 pp. Englisch. Bestandsnummer des Verkäufers 9786209440328
Neu kaufen
EUR 43,90
EUR 60,00 Versand
Versand von Deutschland nach USA
Versand von Deutschland nach USA
Anzahl: 1 verfügbar